Challenges in the therapy of Visceral Leishmaniasis in Brazil: A public health perspective

Journal of Tropical Medicine

Volumn , Issue , 2013, Pages

  De Melo, Edson Carvalho ^a,b   Fortaleza, Carlos Magno Castelo Branco ^b  

^a Secretaria de Estado da Saude de Sao Paulo   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893867420     PISSN: 16879686     EISSN: 16879694     Source Type: Journal    
DOI: 10.1155/2013/319234     Document Type: Review

References (44)

1. World Health Orgazination, Leishmaniasis: epidemiology and access to medicines-an update based on the outcomes of WHO regional meetings, literature review and experts' opinion, Geneve (WHO). 2012, http://www.who.int/ leishmaniasis/resources/Leishmaniasis-worldwide-epidemiological-and-drug-access- update.pdf
2. Chappuis F., Sundar S., Hailu A., Ghalib H., Rijal S., Peeling R. W., Alvar J., Boelaert M., Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nature Reviews Microbiology 2007 5 11 873 882 2-s2.0-35348871028 10.1038/nrmicro1748
3. Alvar J. J, Vélez I. D., Bern C. C, Herrero M., Desjeux P., Cano J., Jannin J., den Boer M., Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012 7 5 e35671 10.1371/journal.pone.0035671
4. Pelissari D. M., Cechinel M. P., Souza-Gomes M. L., Lima Junior F. E., Tratamento da leishmaniose visceral e tegumentar americana no Brasil. Epidemiologia e Serviços de Saúde 2011 20 1 107 110
5. Maia-Elkhoury A. N. S., Alves W. A., De Sousa-Gomes M. L., De Sena J. M., Luna E. A., Visceral leishmaniasis in Brazil: trends and challenges. Cadernos de Saúde Publica 2008 24 12 2941 2947 2-s2.0-57749119428 10.1590/S0102-311X2008001200024
6. Harhay M. O., Olliaro P. L., Costa D. L., Costa C. H. N., Urban parasitology: visceral leishmaniasis in Brazil. Trends in Parasitology 2011 27 9 403 409 2-s2.0-80051794731 10.1016/j.pt.2011.04.001
7. Costa C. H., Tapety C. M., Werneck G. L., Controle da leishmaniose visceral em meio urbano: estudo de intervenção randomizado fatorial. Revista da Sociedade Brasileira de Medicina Tropical 2007 40 4 415 419 10.1590/S0037-86822007000400009 (Pubitemid 47395239)
8. Romero G. A. S., Boelaert M., Control of visceral leishmaniasis in latin America-a systematic review. PLoS Neglected Tropical Diseases 2010 4 1 e584 2-s2.0-76249122179 10.1371/journal.pntd.0000584
9. Centro de vigilância epidemiológica da secretaria de estado da saúde de são paulo, Leishmaniose visceral Americana: dados estatísticos. 2013, http://www.cve.saude.sp.gov.br/htm/zoo/leishv-dados. html
10. Madalosso G., Fortaleza C. M., Ribeiro A. F., Cruz L. L., Nogueira P. A., Lindoso J. A., American visceral leishmaniasis: factors associated with lethality in the state of são paulo, Brazil. Journal of Tropical Medicine 2012 2012 7 281572 10.1155/2012/281572
11. Kocyigit A., Gur S., Gurel M. S., Bulut V., Ulukanligil M., Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasis. Infection and Immunity 2002 70 12 6589 6591 2-s2.0-0036892199 10.1128/IAI.70.12.6589-6591.2002 (Pubitemid 35387885)
12. Muniz-Junqueira M. I., de Paula-Coelho V. N., Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF- α production, but only via TNF- α it indirectly increases nitric oxide production by phagocytes of healthy individuals, in vitro. International Immunopharmacology 2008 8 12 1633 1638 2-s2.0-54549119285 10.1016/j.intimp.2008.07.011
13. de Saldanha R. R., Martins-Papa M. C., Sampaio R. N., Muniz-Junqueira M. I., Meglumine antimonate treatment enhances phagocytosis and TNF- α production by monocytes in human cutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 2012 106 10 596 603 10.1016/j.trstmh.2012.07.001
14. Mondal S., Bhattacharya P., Ali N., Current diagnosis and treatment of visceral leishmaniasis. Expert Review of Anti-Infective Therapy 2010 8 8 919 944 2-s2.0-77955584094 10.1586/eri.10.78
15. Brustoloni Y. M., Cunha R. V., Cônsolo L. Z., Oliveira A. L. L., Dorval M. E. C., Oshiro E. T., Treatment of visceral leishmaniasis in children in the central-west region of Brazil. Infection 2010 38 4 261 267 2-s2.0-77956057593 10.1007/s15010-010-0022-3
16. De Oliveira A. L. L., Brustoloni Y. M., Fernandes T. D., Dorval M. E. C., Da Cunha R. V., Bóia M. N., Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil. Tropical Doctor 2009 39 3 180 182 2-s2.0-67650392062 10.1258/td.2008.080369
17. Ministério Da Saúde, Secretaria De Vigilância Em Saúde, Manual De Vigilância E Controle Da Leishmaniose Visceral 2006 Brasília, Brazil Departamento De Vigilância Epidemiológica
18. Cota G. F., de Sousa M. R., Fereguetti T. O., Rabello A., Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison. PLoS Neglected Tropical Diseases 2013 7 5 e2195 10.1371/journal.pntd.0002195
19. Murray H. W., Progress in the treatment of a neglected infectious disease: visceral leishmaniasis. Expert Review of Anti-Infective Therapy 2004 2 2 279 292 2-s2.0-2942612454 10.1586/14787210.2.2.279 (Pubitemid 38735771)
20. H1 immune response in amphotericin B-treated mucocutaneous leishmaniasis. Journal of Biomedicine and Biotechnology 2007 2007 4 2-s2.0-34250882127 10.1155/2007/96410 96410 (Pubitemid 46987701)
21. 2 production via cyclooxygenase pathway by macrophages. Journal of Cellular Biochemistry 2000 77 3 361 371 10.1002/(SICI)1097-4644(20000601)77: 3361::AID-JCB2>3.0.CO;2-W (Pubitemid 30230591)
22. Ehrenfreund-Kleinman T., Domb A. J., Jaffe C. L., Nasereddin A., Leshem B., Golenser J., The effect of amphotericin B derivatives on Leishmania and immune functions. Journal of Parasitology 2005 91 1 158 163 2-s2.0-17844385560 10.1645/GE-3379 (Pubitemid 40804315)
23. Sundar S., Chatterjee M., Visceral leishmaniasis-current therapeutic modalities. Indian Journal of Medical Research 2006 123 3 345 352 2-s2.0-33745224305 (Pubitemid 43905574)
24. Ministério Da Saúde, Secretaria De Vigilância Em Saúde, Leishmaniose Visceral: RecomenDações Clínicas Para Redução Da letalidade 2011 Brasília, Brazil Departamento De Vigilância Epidemiológica
25. Ministério Da Saúde, Secretaria De Vigilância Em Saúde, Novo Protocolo de Tratamento Para a Leishmaniose Visceral 2013 Brasília, Brazil Departamento De Vigilância Epidemiológica
26. Cifani C., Costantino S., Massi L Berrino M., Commercially available lipid formulations of amphotericin b: are they bioequivalent and therapeutically equivalent? Acta Biomedica 2012 83 2 154 163
27. Mohamed-Ahmed A. H., Brocchini S., Croft S. L., Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis. Current Opinion in Infectous Diseases 2012 25 6 695 702 10.1097/QCO.0b013e328359eff2
28. Sundar S., Chakravarty J., Agarwal D., Rai M., Murray H. W., Single-dose liposomal amphotericin B for visceral leishmaniasis in India. The New England Journal of Medicine 2010 362 6 504 512 2-s2.0-76649099805 10.1056/NEJMoa0903627
29. Sundar S., Chakravarty J., Leishmaniasis: an update of current pharmacotherapy. Expert Opinion in Pharmacotherapy 2013 14 1 53 63 10.1517/14656566.2013.755515
30. Balasegaram M., Ritmeijer K., Lima M. A., Burza S., Genovese G. O., Milani B., Gaspani S., Potet J., Chappuis F., Liposomal amphotericin B as a treatment for human leishmaniasis. Expert Opinion on Emerging Drugs 2012 17 4 493 510 10.1517/14728214.2012.748036
31. São Paulo (Estado), Secretaria de Estado da Saúde, Superintendência de Controle de Endemias-SUCEN e Coordenadoria de Controle de Doenças, Manual de Vigilância e Controle da Leishmaniose Visceral Americana do Estado de São Paulo. Secretaria de Saúde, São Paulo, Brazil, 2006
32. Vanlerberghe V., Diap G., Guerin P. J., Meheus F., Gerstl S., Stuyft P. V. D., Boelaert M., Drug policy for visceral leishmaniasis: a cost-effectiveness analysis. Tropical Medicine and International Health 2007 12 2 274 283 2-s2.0-33846992325 10.1111/j.1365-3156.2006.01782.x
33. Olliaro P. L., Guerin P. J., Gerstl S., Haaskjold A. A., Rottingen J. A., Sundar S., Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infectious Diseases 2005 5 12 763 774 2-s2.0-28044469320 10.1016/S1473-3099(05)70296-6 (Pubitemid 41688981)
34. Werneck G. L., Batista M. S. A., Gomes J. R. B., Costa D. L., Costa C. H. N., Prognostic factors for death from visceral leishmaniasis in Teresina, Brazil. Infection 2003 31 3 174 177 2-s2.0-0038792351 (Pubitemid 36737040)
35. Sampaio M. J. A. D. Q., Cavalcanti N. V., Alves J. G. B., Filho M. J. C. F., Correia J. B., Risk factors for death in children with visceral leishmaniasis. PLoS Neglected Tropical Diseases 2010 4 11 e877 2-s2.0-79954435613 10.1371/journal.pntd.0000877
36. de Araújo V. E. M., Morais M. H. F., Reis I. A., Rabello A., Carneiro M., Early clinical manifestations associated with death from visceral leishmaniasis. PLoS Neglected Tropical Diseases 2012 6 2 e1511 2-s2.0-84857822649 10.1371/journal.pntd.0001511 e1511
37. Rabello A., Orsini M., Disch J., Leishmania/HIV co-infection in Brazil: an appraisal. Annals of Tropical Medicine and Parasitology 2003 97 supplement 1 17 28 2-s2.0-0345689365 10.1179/000349803225002507
38. Alvar J., Aparicio P., Aseffa A., Den Boer M., Cañavate C., Dedet J.-P., Gradoni L., Ter Horst R., López-Vélez R., Moreno J., The relationship between leishmaniasis and AIDS: the second 10 years. Clinical Microbiology Reviews 2008 21 2 334 359 2-s2.0-42349108596 10.1128/CMR.00061-07 (Pubitemid 351555511)
39. Souza-Gomes M. L., Maia-Elkhoury A. N., Pelissari D. M., Lima Junior F. E., Sena J. M., Cechinel M. P., Coinfecção Leishmania-HIV no Brasil: aspectos epidemiológicos, clínicos e laboratoriais. Epidemiologia e Serviços de Saúde 2011 20 4 519 526
40. Jarvis J. N., Lockwood D. N., Clinical aspects of visceral leishmaniasis in HIV infection. Current Opinion in Infectious Diseases 2013 26 1 1 9 10.1097/QCO.0b013e32835c2198
41. Daher E. F., Fonseca P. P., Gerhard E. S., Silva Leitão T. M. J., Silva Júnior G. B., Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil. Journal of Parasitology 2009 95 3 652 655 2-s2.0-73949083849 10.1645/GE-1678.1
42. Cota G. F., de Sousa M. R., Rabello A., Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review. PLoS Neglected Tropical Diseases 2011 5 6 e1153 2-s2.0-79959822382 10.1371/journal.pntd.0001153 e1153
43. Flaer P. J., Younis M. Z., The Brazilian experiment: HIV drugs for all. Journal of Health Care Finance 2009 36 2 90 96 2-s2.0-74049127901
44. van Griensven J., Balasegaram M., Meheus F., Alvar J., Lynen L., Boelaert M., Combination therapy for visceral leishmaniasis. The Lancet Infectious Diseases 2010 10 3 184 194 2-s2.0-77049105214 10.1016/S1473-3099(10)70011-6